| Thalidomide plus prednisone with or without danazol therapy in myelofibrosis: a retrospective analysis of incidence and durability of anemia response | |
| Luo, Xueping; Xu, Zefeng; Li, Bing; Qin, Tiejun; Zhang, Peihong; Zhang, Hongli; Fang, Liwei; Pan, Lijuan; Hu, Naibo; Qu, Shiqiang | |
| 2018 | |
| 卷号 | 8期号:1页码:9 |
| ISSN号 | 2044-5385 |
| DOI | 10.1038/s41408-017-0029-4 |
| URL标识 | 查看原文 |
| 收录类别 | SCIE ; PUBMED |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6361033 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Luo, Xueping,Xu, Zefeng,Li, Bing,et al. Thalidomide plus prednisone with or without danazol therapy in myelofibrosis: a retrospective analysis of incidence and durability of anemia response[J],2018,8(1):9. |
| APA | Luo, Xueping.,Xu, Zefeng.,Li, Bing.,Qin, Tiejun.,Zhang, Peihong.,...&Xiao, Zhijian.(2018).Thalidomide plus prednisone with or without danazol therapy in myelofibrosis: a retrospective analysis of incidence and durability of anemia response.,8(1),9. |
| MLA | Luo, Xueping,et al."Thalidomide plus prednisone with or without danazol therapy in myelofibrosis: a retrospective analysis of incidence and durability of anemia response".8.1(2018):9. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论